To date, no data exists with regard to AAT-1 effects in the settings of CPB. The primary goals of this study are to evaluate anti-inflammatory effects, organ function preservation (1-2) and postoperative blood loss reduction following AAT-1 administration in patients undergoing cardiac surgery with CPB.